By Admin at 31 Jul 2017
The meta-analysis of nearly 12,500 glioma cases (and 18,000 people without glioma) revealed 13 new genetic markers that are linked to an increased risk of glioma.
By Admin at 3 Feb 2017
February 4 is World Cancer Day, a day to unite the globe in the fight against cancer. By raising awareness, open conversations can be started to press governments and individuals to take action against this disease.
By Admin at 12 Jan 2017
A Gateway-funded clinical trial is making big news for breakthrough success in brain cancer. For the first time, researchers have successfully used a form of immunotherapy, which harnesses a patient’s own immune system to fight cancer, to treat an aggressive type of brain tumor called glioblastoma.
By Admin at 29 Feb 2016
Glioblastoma is the most common type of brain cancer. It’s often aggressive and has a median survival time of under 15 months on average. Researchers are offering new hope for treatment in this area using an unlikely “weapon” – herpes virus.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial